In last week’s Solidarity Fridays episode, Kyle, Joe, and Michelle talked a lot about a landmark new trial to study microdosing and the placebo effect. And this week (the big SF50!), they’re joined by 2 key members of that very trial, lead researcher Balázs Szigeti and principal investigator David Erritzoe.  Szigeti and Erritzoe explain all …

The post PTSF50 – Microdosing and the Placebo Effect, with Balázs Szigeti and David Erritzoe appeared first on Psychedelics Today.

Previous articleAion Therapeutic Files 4 New Patent Applications (Including for the Treatment of Human Cancers)
Next articleCan Psilocybin Assisted Psychotherapy Change Attachment Style?